The pemetrexed-induced “flare” also appears predictive of NSCLC sensitivity to pemetrexed[5] raising the possibility that FLT-PET may be a useful imaging tool for determining successful TS inhibition in NSCLC patients. This evidence concerns the gene TYMS and non-small cell lung carcinoma.